What is the main reason for this 8-K filing?

This 8-K filing is primarily to announce that HCA Healthcare expects its full-year 2013 Adjusted EBITDA to be significantly higher than previously guided, specifically between $65 million and $75 million above the upper end of their prior forecast.

How does this expected performance compare to prior guidance?

The company had previously guided for 2013 Adjusted EBITDA in the range of $6.25 billion to $6.50 billion. This announcement means their actual or expected results are likely to be in the range of $6.315 billion to $6.575 billion or even higher, surpassing the initial projections.

What does 'Adjusted EBITDA' mean for investors?

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a non-GAAP financial measure used by companies to provide a sense of their operating performance. An increase above guidance suggests improved operational efficiency, higher revenues, or better cost management during 2013, which is generally viewed as a positive sign for the company's financial health and profitability.

Are there any specific reasons provided for this improved performance?

The 8-K filing itself does not detail the specific reasons for the expected outperformance. It references a press release (Exhibit 99.1) which likely contains more color, but the core disclosure here is the revised financial expectation.

HCA 8-K: Earnings & Results & Regulation FD

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on January 14, 2014, to disclose that it anticipates its 2013 Adjusted EBITDA to significantly exceed its previously issued guidance. The company expects its Adjusted EBITDA to be between $65 million and $75 million above the high-end of its prior forecast, which ranged from $6.25 billion to $6.50 billion. This upward revision suggests a stronger-than-expected operational performance for HCA in 2013. Investors should view this news positively, as it indicates improved profitability and potentially better cash flow generation than initially projected. The filing serves as a crucial update on the company's financial condition and operational results leading up to the end of the fiscal year.

Key Highlights

1HCA Healthcare anticipates 2013 Adjusted EBITDA to be $65 million to $75 million above the high-end of previous guidance.
2The company's previously issued 2013 Adjusted EBITDA guidance range was $6.25 billion to $6.50 billion.
3This disclosure indicates a positive variance and stronger-than-expected financial performance for 2013.
4The information was disclosed via a press release filed as Exhibit 99.1 to the 8-K.
5The filing was made on January 14, 2014, reflecting events on January 13, 2014.
6The Chief Financial Officer, William B. Rutherford, signed the report, signifying official confirmation.

HCA Healthcare, Inc. 8-K Report, Financial Results (Jan 14, 2014)

Summary

Key Highlights

Frequently Asked Questions